Intelligent Investors take on the DNA AGM:
Four directors were rolled at Donaco’s (DNA, 1%)
blockbuster AGM, leaving two representatives of major
shareholder Argyle Street Management on the board.
Argyle must now appoint several new directors to meet
board size and residency requirements. The outcome
doesn’t jeopardize Donaco’s Singaporean legal claim
but it gives Argyle complete control of Donaco’s future.
Minorities shouldn’t have anything to fear if Argyle’s past
investments are anything to go by, including a profitable
stint at Mt Gibson Iron (ASX:MGX). A fresh pair of eyes
makes Argyle’s better suited to settling Donaco’s Star
Vegas dispute, too. But it’s a situation we’re watching
closely and managing with our position size.
https://cdn-blob.investsmart.com.au/distributions/documents/portfolio-performance-updates/november-2019/Monthly_Update_Nov_2019__II_Aus_Small_Companies_Fund.pdf
